tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Ocumension Therapeutics Gains Approval for OT-702 in China
Company AnnouncementsOcumension Therapeutics Gains Approval for OT-702 in China
19d ago
1477
Ocumension Therapeutics Reports Strong Revenue Growth Amid Product Expansion
PremiumCompany Announcements
Ocumension Therapeutics Reports Strong Revenue Growth Amid Product Expansion
4M ago
1477
Ocumension’s OT-301 Achieves Key Milestone in Phase III Trial
PremiumCompany Announcements
Ocumension’s OT-301 Achieves Key Milestone in Phase III Trial
4M ago
1477
Ocumension Therapeutics to Review Interim Results in Upcoming Board Meeting
PremiumCompany Announcements
Ocumension Therapeutics to Review Interim Results in Upcoming Board Meeting
4M ago
1477
Ocumension Therapeutics Updates Nomination Committee
PremiumCompany Announcements
Ocumension Therapeutics Updates Nomination Committee
6M ago
1477
Ocumension Therapeutics Announces Board Composition and Roles
PremiumCompany AnnouncementsOcumension Therapeutics Announces Board Composition and Roles
6M ago
1477
Ocumension Therapeutics Updates Nomination Committee Terms
Premium
Company Announcements
Ocumension Therapeutics Updates Nomination Committee Terms
6M ago
1477
Promising Outlook for Ocumension Therapeutics: Buy Rating Backed by Strategic Developments and Regulatory Milestones
Premium
Ratings
Promising Outlook for Ocumension Therapeutics: Buy Rating Backed by Strategic Developments and Regulatory Milestones
6M ago
Ocumension Therapeutics Revamps Share Option Scheme to Boost Employee Incentives
PremiumCompany Announcements
Ocumension Therapeutics Revamps Share Option Scheme to Boost Employee Incentives
6M ago
1477
Ocumension Therapeutics Successfully Passes All AGM Resolutions
PremiumCompany Announcements
Ocumension Therapeutics Successfully Passes All AGM Resolutions
6M ago
1477
Ocumension Therapeutics Gains Approval for Phase III Trial of Presbyopia Treatment in China
PremiumCompany Announcements
Ocumension Therapeutics Gains Approval for Phase III Trial of Presbyopia Treatment in China
6M ago
1477
Ocumension’s OT-703 Approved for Study in Hainan
PremiumCompany Announcements
Ocumension’s OT-703 Approved for Study in Hainan
7M ago
1477
Ocumension Therapeutics Announces 2025 Annual General Meeting
PremiumCompany AnnouncementsOcumension Therapeutics Announces 2025 Annual General Meeting
8M ago
1477
Ocumension Therapeutics Proposes Amendments to Optimize Operations
Premium
Company Announcements
Ocumension Therapeutics Proposes Amendments to Optimize Operations
9M ago
1477
Ocumension Therapeutics Reports Significant Revenue Growth and Strategic Advancements in 2024
Premium
Company Announcements
Ocumension Therapeutics Reports Significant Revenue Growth and Strategic Advancements in 2024
9M ago
1477
Ocumension Therapeutics to Review Annual Financial Results and Dividend Proposal
PremiumCompany Announcements
Ocumension Therapeutics to Review Annual Financial Results and Dividend Proposal
9M ago
1477
Ocumension Therapeutics Reports Significant Revenue Growth in 2024
PremiumCompany Announcements
Ocumension Therapeutics Reports Significant Revenue Growth in 2024
10M ago
1477
Ocumension Therapeutics Announces Board Composition and Strategic Roles
PremiumCompany Announcements
Ocumension Therapeutics Announces Board Composition and Strategic Roles
11M ago
1477
Ocumension Therapeutics Announces Director Resignation and New Appointment
PremiumCompany Announcements
Ocumension Therapeutics Announces Director Resignation and New Appointment
11M ago
1477
Ocumension Therapeutics Announces Change in Share Registrar
PremiumCompany AnnouncementsOcumension Therapeutics Announces Change in Share Registrar
11M ago
1477
Ocumension Advances Phase III Trials for Key Drug
Premium
Company Announcements
Ocumension Advances Phase III Trials for Key Drug
1y ago
1477
Ocumension Faces Gender Diversity Challenge After Director Resignation
Premium
Company Announcements
Ocumension Faces Gender Diversity Challenge After Director Resignation
1y ago
1477

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >